Columbia Med. Professor Tied To Hedge Fund Insider-Trading Case

Sep 19 2011 | 4:40am ET

A Columbia University medical professor is alleged to have passed confidential information about a drug trial to a Cambridge, Mass., hedge fund.

Andrew Bomback is the tipster identified as “Doctor 1” in Massachusetts’ civil lawsuit against Risk Reward Capital and its founder, James Silverman, The New York Times reports. The Gray Lady was able to determine Bomback’s identity by comparing the lawsuit and a press release from one of the companies that Silverman is accused of trading illegally, Questcor Pharmaceuticals.

“I’m actually surprised you were able to identify me,” Bomback, who is a consultant for Questcor, told the Times. But he admitted that he is “Doctor 1.”

Bomback is not accused of any wrongdoing by Massachusetts regulators, and denies breaking the law, as does Silverman.

“Mr. Silverman has never received any material, non-public information from me,” he told the Times.

Massachusetts begs to differ: It say that Risk Reward’s performance turned around once it began working with expert-network Guidepoint Global. Guidepoint put Silverman in touch with Bomback, who probably knew more about Questcor’s only drug than any other person, having reviewed all 21 of the patient files from the test—eight of the patients were his own.

Bomback said he only spoke with Silverman about his patients. But Silverman’s notes, turned over to the authorities as part of the investigation, show that the two actually discussed all 21 cases.

The case has led Massachusetts to impose new rules covering expert networks.


In Depth

Whisky Business: The Ultimate Liquid Alternative Investment

Sep 15 2014 | 7:02am ET

David Robertson knows his single-malt whisky—he was the Master Distiller at the...

Lifestyle

Hedgies Rock Out For Children's Charity

Sep 15 2014 | 8:40am ET

It's that time of year again—when hedgies trade in their spreadsheets for guitars...

Guest Contributor

Volkered: How Financial Sector Reforms are Creating Opportunities for Hedge Funds

Sep 16 2014 | 11:28am ET

New regulations have dramatically curtailed proprietary trading activity in investment...

 

Editor's Note

    Get A Sneak Peak Of The Alpha Pages

    Aug 25 2014 | 11:21am ET

    As many of you know, FINalternatives was recently acquired by the owners of Futures magazine, a firm called The Alpha Pages LLC. Today marks the soft-launch of a new sister site for both publications. As its name suggests, The Alpha Pages will cover all types of alternative investments, going far beyond the more well-known ones such as hedge funds and private equity. Read more…

 

Futures Magazine

September 2014 Cover

The London Whale: Rogue risk management

Credit default swaps brought down the London Whale and cost JPMorgan $6.2 billion. Here is how it happened.

The Alpha Pages

TAP July/August 2014 Cover

The Alpha Pages Interview: Senator Rand Paul

Senator Paul sat down in the debut series of the Alpha Pages Interview to discuss the broken tax code, regulation surrounding Bitcoin, and his plans for the 2016 Presidential election.